Catalyst Wire Dossier Catalyst Wire Dossier

Vitreosolve

· Vitreoretinal Technologies, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Vitreosolve, covering 2009-10-20 to 2009-10-20. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects [Phase 2, Phase 3]

See pricing